InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
T+90 hit rate
33%
T+90 mean return
-4.7%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Lynch Alissa Hsu, Director. Officer active across 2 companies, notably Pulmonx Corp. In total, 9 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €9k. Activity tracked since 1 September 2021. The latest transaction was disclosed on 28 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
38,252 shares0Common StockSEC:0001875681-25-000010:0
9,348 shares@ US$7.49100.0% of flowCommon StockSEC:0001875681-25-000008:0
60,569 shares0Common StockSEC:0001875681-24-000002:0
112,908 shares0Common StockSEC:0001875681-23-000005:0
12,620 shares0Common StockSEC:0001209191-23-034003:0
1,700 shares@ US$5.51100.0% of flowCommon StockSEC:0001209191-22-059221:0
Ideal exit: 26 Aug 2023 (T+270)
5,600 shares0Common StockSEC:0001209191-22-034280:0
4,610 shares0Common StockSEC:0001209191-21-054851:0
4,610 shares0Common StockSEC:0001209191-21-054851
9 of 9 declarations
About Lynch Alissa Hsu
Alissa Hsu Lynch is a Director at Pulmonx Corp. In this role, she participates in strategic decision-making and governance of the company. Her experience and skills are leveraged to guide management and ensure value creation for shareholders.
